Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.79 |
| ▸ | CNR1 | P21554 | 7/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Canbisol SCHEMBL2109878 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Canbisol SCHEMBL11742031 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Canbisol SCHEMBL11734297 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Canbisol SCHEMBL23601992 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Canbisol SCHEMBL11737376 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL23602227 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Canbisol SCHEMBL11728974 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL17414499 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Canbisol SCHEMBL2109880 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Canbisol SCHEMBL27448557 | 1.00 | CNR2 (0.79) | CNR2CNR1NR1I2ADORA3SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |